Skip to main content

AMERIPRISE FINANCIAL INC

Position in GH — Guardant Health, Inc.

CIK 820027 MINNEAPOLIS, MN

Position in GH

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$472,729,076
+$342,036,057 QoQ
Shares Held
3,150,897
+122.7% QoQ
Ownership
2.35%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#12
of 594 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 0% Shared 94% None 6%

Common Shares in GH Over Time

Shares Held

Position Value (USD)

Derivatives in GH

reported options exposure · as of Mar 31, 2026
CallValue
$0
CallShares
0
PutValue
$4,295,205
PutShares
46,500

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

AMERIPRISE FINANCIAL INC holds $3,438,572,158 across 31 Diagnostics & Research names. GH ranks #2 (13.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 GH
Guardant Health, Inc.
This page
3,150,897 $472,729,076

All Filings in GH

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $472,729,076 3,150,897
2026-03-31 $130,693,019 1,414,886
2026-03-31 $4,295,205 46,500
2025-12-31 $77,891,451 762,595
2025-09-30 $19,211,412 307,481
2025-06-30 $25,753,138 494,872
2025-03-31 $6,945,886 163,049
2024-12-31 $4,740,290 155,165
2024-09-30 $1,813,200 79,041
2024-06-30 $2,080,197 72,029
2024-03-31 $491,859 23,842
2023-12-31 $13,037,991 481,996
2023-09-30 $12,419,247 419,003
2023-06-30 $13,841,675 386,639
2022-09-30 $533,831 9,917
2022-06-30 $395,977 9,816
2022-03-31 $333,120 5,029
2021-12-31 $882,775 8,826
2021-09-30 $854,942 6,839
2021-06-30 $2,562,783 20,636
2021-03-31 $4,672,158 30,607
2020-12-31 $5,793,412 44,952
2020-09-30 $81,963,130 733,254
2020-06-30 $76,344,138 941,010
2020-03-31 $90,657,547 1,302,551